Purchase Order HHSN319201700004P

The NIH Clinical Center awarded a purchase order to Research and Diagnostic Systems, Inc. valued at $9,325.35 on July 16, 2019, with performance completion targeted for July 31, 2019. The order is firm-fixed-price, issued under no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures biological research materials and laboratory supplies—including recombinant proteins, antibodies, ELISA kits, and specialized reagents—from R&D Systems' established product catalog...

The NIH Clinical Center awarded a purchase order to Research And Diagnostic Systems, Inc. for $29,103.00 on March 27, 2019, with completion scheduled for April 30, 2019. No set-aside was used. Performance occurs in Bethesda, Maryland. The purchase order procures biological research materials and reagents—the company supplies recombinant human proteins, antibodies, ELISA kits, cytokine assays, fetal bovine serum, and specialized laboratory supplies supporting biomedical research across NIH...

This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Research and Diagnostic Systems, Inc. is valued at $445,214.70 to deliver 89 items including 27 types of recombinant human proteins and 12 small molecule compounds by June 30, 2021. As the sole source provider, Research and Diagnostic Systems will ship the products from its Minneapolis location within 14 days of each order to support the Center's consistent research...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Research And Diagnostic Systems, Inc. for various reagents with a ceiling value of $22,045.00 on September 14, 2017. The order was firm fixed price with no set-aside. Place of performance is Bethesda, Maryland. The ultimate completion date is January 31, 2018.</p>

<p>The National Center for Advancing Translational Sciences awarded a purchase order to Cisbio US, Inc. for $19,225.00 on September 25, 2019. The order was issued under a Total Small Business set-aside solicitation posted August 29, 2019. Work is performed in Bedford, Massachusetts. The purchase order covers assay kits and reagents for biomarker detection and disease research. The order has a firm fixed price and an ultimate completion date of October 31, 2019.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,250.50 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&amp;D Systems, a division of Bio-Techne Corporation. The contract is for research and development reagents to be delivered from October 17, 2023 through November 6, 2023. As the prime contractor, R&amp;D Systems will provide laboratory supplies and materials to support the NIH Clinical Center's...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...

<p>The National Center for Advancing Translational Sciences awarded a purchase order to Research and Diagnostic Systems, Inc. for $10,000 on January 24, 2020, for one milligram of recombinant human ALDH1B1 custom purification service and test sample. Performance occurs in Minneapolis, Minnesota. The order carries firm fixed price terms and no set-aside designation.</p>

This firm-fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Research And Diagnostic Systems, Inc. (doing business as R&amp;D Systems) for $31,045.00. The award supported a requirement for an Ub-AML substrate for a DUB3 project at the NIH's National Center for Advancing Translational Science (NCATS) Chemical Genomics Center. R&amp;D Systems, a for-profit manufacturer, was the sole...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Research And Diagnostic Systems, Inc. for a variety of antibodies valued at $34,920.35, effective September 20, 2018, with completion targeted for September 20, 2019. Place of performance is Minneapolis, Minnesota. The order was issued under open competition with no set-aside applied, following a solicitation posted August 13, 2018 and due August 22, 2018.</p>